> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Continuous Manufacturing Proposal
- URL: https://www.fdaweb.com/comments-sought-on-continuous-manufacturing-proposal/
- Published: 2017-06-23T12:00:00.000Z
- Updated: 2026-09-14T22:31:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139010

*Federal Register* notice: FDA is seeking comments on a submission involving proposed recommendations for industry on developing continuous manufacturing for solid dosage drug products. The **Center for Structured Organic Particulate Systems** (C-SOPS) recently submitted an [industry-coordinated best practices document](https://www.regulations.gov/docket?D=FDA-2017-N-2697&ref=fdaweb.com) on continuous manufacturing. FDA is interested in public comments about the science, technology, and practices discussed in the C-SOPS document. In addition, the agency is seeking comments on other recommendations regarding continuous manufacturing that have already been published, including the 2014 continuous manufacturing symposium “Regulatory and Quality Considerations for Continuous Manufacturing.” To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-06-23/pdf/2017-13195.pdf?ref=fdaweb.com).